Background illustration for clinical trials search

Paid Clinical Trials Lakeland

Discover 1,839 paid clinical trials in Lakeland, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Phase 1/2a Study of DB-2304 in Healthy Adults and SLE/CLE Participants

for
Systemic Lupus Erythematosus (SLE) or Cutaneous Lupus Erythematosus,
Location: Orlando FL, Clearwater FL, Irving TX, San Antonio TX,
Sponsor: DualityBio Inc.

Sex: All

Age: 18 - 70

Code: NCT06625671

Phase1, Phase2, Recruiting

A Study to Investigate Tislelizumab Administered as Subcutaneous Injection Versus Intravenous Infusion Plus Chemotherapy in Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma

for
Metastatic Gastric Adenocarcinoma,
Location: Orlando FL, Hialeah FL, Nashville TN, Houston TX,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT07043400

Phase3, Recruiting

Phase 3 Trial of Tarlatamab (SC vs IV) in Extensive-Stage Small Cell Lung Cancer After Platinum Based First-line Chemotherapy (ES-SCLC)

for
Small Cell Lung Cancer
Location: Orlando FL, Grand Rapids MI, Omaha NE
Sponsor: Amgen

Sex: All

Age: 18 - 70+

Code: NCT07778316

Phase3, Recruiting

A Randomized Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients With Refractory Advanced/Metastatic Colorectal Cancer

for
Colorectal Cancer
Location: Orlando FL, Miami Beach FL, Charleston SC, Nashville TN,
Sponsor: Criterium, Inc.

Sex: All

Age: 18+

Code: NCT06992258

Phase2, Recruiting

Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia

for
B Acute Lymphoblastic Leukemia
Location: Orlando FL, Hollywood FL, Augusta GA, Columbia SC,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 18 - 39

Code: NCT03150693

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Registry Study for Radiation Therapy Outcomes

for
Neoplasms
Location: Orlando FL, Fort Myers FL, Jacksonville FL,
Sponsor: Proton Collaborative Group

Sex: All

Age: 0+

Code: NCT01255748

Recruiting

A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002)

for
Colitis Ulcerative, Ulcerative Colitis
Location: Orlando FL, Inverness FL, Miami FL, Macon GA,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18 - 70+

Code: NCT07463183

Phase2, Recruiting

A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease

for
Chronic Graft-versus-host-disease
Location: Orlando FL, Pembroke Pines FL, Miami FL, Charleston SC,
Sponsor: Incyte Corporation

Sex: All

Age: 12+

Code: NCT06585774

Phase3, Recruiting

Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.

for
Metastatic Melanoma, Unresectable Melanoma, Melanoma
Location: Orlando FL, Birmingham AL, Nashville TN, Bartlett TN,
Sponsor: Iovance Biotherapeutics, Inc.

Sex: All

Age: 18 - 70

Code: NCT05727904

Phase3, Recruiting

Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

for
Triple-Negative Breast Cancer
Location: Orlando FL, St. Petersburg FL, Altamonte Springs FL,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06393374

Phase3, Recruiting

A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC)

for
Carcinoma, Non-Small-Cell Lung
Location: Orlando FL, Miami FL, Atlanta GA, Pinehurst NC,
Sponsor: Johnson & Johnson Enterprise Innovation Inc.

Sex: All

Age: 18+

Code: NCT06667908

Phase2, Recruiting

Safety and Efficacy of OBX-115 in Advanced Solid Tumors

for
Tumor Skin, Metastatic Melanoma, Melanoma, Lung Cancer,
Location: Orlando FL, Louisville KY, Houston TX, Pittsburgh PA,
Sponsor: Obsidian Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06060613

Phase1, Phase2, Recruiting

Study of Neoadjuvant Chemotherapy Plus Trastuzumab and Pertuzumab in HER2-Negative Breast Cancer Patients With Abnormal HER2 Signaling

for
HER2-negative Breast Cancer
Location: Orlando FL, Miami Beach FL, New Orleans LA,
Sponsor: NSABP Foundation Inc

Sex: Female

Age: 18+

Code: NCT03412643

Phase2, Recruiting

Strategic Timing of Endoscopic Interventions in Infected Necrotizing Pancreatitis

for
Pancreatitis, Acute Necrotizing
Location: Orlando FL
Sponsor: Orlando Health, Inc.

Sex: All

Age: 18+

Code: NCT07406698

Recruiting

A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

for
Inflammatory Bowel Disease (IBD), Ulcerative Colitis (UC),
Location: Orlando FL, Miami FL, Palmetto Bay FL, Pensacola FL,
Sponsor: Mirador Therapeutics, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07113522

Phase2, Recruiting

Randomized Trial of Next Generation Fluoroscopy System vs. Conventional Fluoroscopy System in Endoscopy

for
Radiation Exposure
Location: Orlando FL
Sponsor: Orlando Health, Inc.

Sex: All

Age: 18+

Code: NCT07594132

Recruiting

EUS Procedures Using RIVOS™ EUS Access Device

for
Pancreatic Fluid Collections, Biliary Obstruction,
Location: Orlando FL
Sponsor: Orlando Health, Inc.

Sex: All

Age: 18+

Code: NCT07696572

Recruiting

Randomized Trial of Percutaneous vs. Endoscopic Gallbladder Drainage

for
Acute Cholecystitis
Location: Orlando FL
Sponsor: Orlando Health, Inc.

Sex: All

Age: 18+

Code: NCT07696546

Recruiting

A Dose-masked Study of Intravitreal EYE103 in Participants With NVAMD or Macular Edema Following BRVO

for
Neovascular Age-Related Macular Degeneration (NVAMD),
Location: Orlando FL, Jacksonville FL, Fort Lauderdale FL,
Sponsor: EyeBiotech Ltd.

Sex: All

Age: 18+

Code: NCT07205887

Phase2, Recruiting

AMX0114 in Adult Participants With Amyotrophic Lateral Sclerosis

for
ALS
Location: Orlando FL, Gainesville FL, Jacksonville FL,
Sponsor: Amylyx Pharmaceuticals Inc.

Sex: All

Age: 18+

Code: NCT06665165

Phase1, Recruiting